⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for node negative

Every month we try and update this database with for node negative cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsNCT02625935
Breast Cancer
- NanoString Technologies, Inc.
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536
Breast Cancer
bevacizumab
docetaxel
doxorubicin
cyclophosphamid...
pegfilgrastim
18 Years - 70 YearsNSABP Foundation Inc
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature AssayNCT01899079
Breast Cancer
- NanoString Technologies, Inc.
Sentinel Node Biopsy in Early Oral Cancers a Tertiary Cancer Centre ExperienceNCT05950737
Oral Cavity Squ...
Sentinel node b...
18 Years - 75 YearsTata Memorial Hospital
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsNCT02625935
Breast Cancer
- NanoString Technologies, Inc.
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536
Breast Cancer
bevacizumab
docetaxel
doxorubicin
cyclophosphamid...
pegfilgrastim
18 Years - 70 YearsNSABP Foundation Inc
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsNCT02625935
Breast Cancer
- NanoString Technologies, Inc.
Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast CancerNCT02992574
Breastcancer
Post Mastectomy...
18 Years - 80 YearsTata Memorial Centre
A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature AssayNCT01899079
Breast Cancer
- NanoString Technologies, Inc.
Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast CancerNCT02992574
Breastcancer
Post Mastectomy...
18 Years - 80 YearsTata Memorial Centre
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: